Nature Reviews Nephrology

Papers
(The H4-Index of Nature Reviews Nephrology is 63. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
A UMOD variant with intermediate effects552
Multifaceted innovations needed to advance transplant nephrology355
YAP and TAZ regulate stromal cell development327
In vivo slit diaphragm dynamics in Drosophila294
Genetics of posterior urethral valves270
Wnt–Fzd signals put the brakes on nephrogenesis269
Ferroptotic stress promotes the AKI to CKD transition269
Targeting OSBPL7 restores cholesterol efflux243
Daratumumab for AL amyloidosis226
DPEP1 mediates neutrophil and monocyte influx200
Mentorship in the lives of scholars196
KIM-1 targeted extracellular vesicles for AKI195
Mechanism of B cell survival in lupus nephritis184
Gene therapy in a model of nephrotic syndrome163
Progress in xenotransplantation: overcoming immune barriers162
Opioids for chronic pain management in patients with dialysis-dependent kidney failure158
Vaccination in patients with kidney failure: lessons from COVID-19152
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia151
Unmet care needs of minority groups on dialysis146
A recombinant fusion protein clears IgA deposits140
EPO regulates antibody production via TFH cells140
Dietary protection of proximal tubules in diabetes133
Embryo complementation to generate a humanized mesonephros in pigs127
Unconventional T cells and kidney disease126
Chronic cardiovascular–kidney disorder: a new conceptual framework123
Mannose as a driver of γδ T cell kidney infiltration123
Targeting IL-1Ra to attenuate fungal infection121
Born too soon: lifelong kidney risks and the importance of early intervention115
Approaches to raise awareness of CKD among patients and the general population113
Lived experience is essential for innovation in biomedical research112
The evolving complexity of the collecting duct renin–angiotensin system in hypertension111
The kidney is a novel target of metformin108
Steps forward in the treatment of IgA nephropathy108
Role of the gut microbiota in the pathogenesis of IgA nephropathy108
ECM remodelling by ADAMTS12 in fibrosis108
Progression and outcomes of rare kidney diseases105
Cross-species evolution of capsid libraries for gene delivery to the kidneys105
The immunoregulatory roles of non-haematopoietic cells in the kidney103
Kidney health within the broader non-communicable disease agenda102
Author Correction: Conceptual advances and evolving terminology in acute kidney disease101
Age-old musings: twenty-first century management of advanced kidney disease in older individuals99
Home monitoring of patients with chronic kidney disease99
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes96
Healthy ageing and the kidney — lessons from centenarians96
Polygenic scores and their applications in kidney disease95
Blockchain in nephrology89
Making advance care planning easier for adults with kidney disease and their clinicians89
Epithelial cell states associated with kidney and allograft injury88
Electronic patient-reported outcomes in chronic kidney disease84
Advancing gender equity to improve kidney care for women: a patient perspective82
A guide to gene–disease relationships in nephrology82
Nephrology education and training in Africa79
Big Data in Nephrology76
Evolutionary genetics and acclimatization in nephrology76
Expanding the therapy options for diabetic kidney disease74
Determining lineage relationships in kidney development and disease73
Kidneys control inter-organ homeostasis73
Kidney disease as a medical complication of eating disorders73
Cryopreservation breaks the organ transplant time barrier72
Artificial intelligence-enabled decision support in nephrology72
Uropathogen and host responses in pyelonephritis70
Use of convalescent plasma in the treatment of COVID-1965
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions63
Targeted identification of risk and treatment of diabetic kidney disease63
The GLP-1 receptor agonist revolution comes to nephrology63
0.12653398513794